ARVINAS, INC.
Total Trades
52
Buys
1
Sells
35
Largest Trade
N/A
Insiders
10
Institutional Funds
158
Inst. Value
$1M+
Activist Filings
32
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Houston John G | Director | SELL | $100K–$500K | 35K | $13.21 | Mar 3, 2026 |
| Loomis David K | Chief Accounting O… | SELL | $1K–$15K | 1K | $12.16 | Feb 25, 2026 |
| Cacace Angela M | Chief Scientific O… | SELL | $15K–$50K | 4K | $12.16 | Feb 25, 2026 |
| Teel Randy | President and CEO | SELL | $50K–$100K | 5K | $12.16 | Feb 25, 2026 |
| Teel Randy | President and CEO | SELL | $50K–$100K | 4K | $11.89 | Feb 18, 2026 |
| Saik Andrew | CFO | SELL | $50K–$100K | 5K | $11.89 | Feb 18, 2026 |
| Cacace Angela M | Chief Scientific O… | SELL | $50K–$100K | 5K | $11.89 | Feb 18, 2026 |
| Berkowitz Noah | Chief Medical Offi… | SELL | $50K–$100K | 6K | $11.89 | Feb 18, 2026 |
| Loomis David K | Chief Accounting O… | SELL | $1K–$15K | 1K | $11.89 | Feb 18, 2026 |
| Loomis David K | Chief Accounting O… | SELL | $1K–$15K | 230 | $9.89 | Nov 7, 2025 |
| Morrison Briggs | Director | BUY | $100K–$500K | 30K | $7.57 | Sep 24, 2025 |
| Saik Andrew | CFO | SELL | $15K–$50K | 6K | $7.61 | Jun 24, 2025 |
| Cacace Angela M | Chief Scientific O… | SELL | $15K–$50K | 3K | $7.49 | Jun 18, 2025 |
| Berkowitz Noah | Chief Medical Offi… | SELL | $50K–$100K | 9K | $8.59 | Mar 19, 2025 |
| Loomis David K | Chief Accounting O… | SELL | $15K–$50K | 1K | $16.75 | Feb 25, 2025 |
| Cacace Angela M | Chief Scientific O… | SELL | $50K–$100K | 4K | $16.70 | Feb 25, 2025 |
| Taylor Ian | President, R&D | SELL | $100K–$500K | 9K | $16.71 | Feb 25, 2025 |
| Houston John G | President and CEO | SELL | $500K+ | 31K | $16.72 | Feb 25, 2025 |
| Loomis David K | Chief Accounting O… | SELL | $1K–$15K | 460 | $22.39 | Nov 12, 2024 |
| Houston John G | President and CEO | SELL | $100K–$500K | 5K | $47.05 | Feb 27, 2024 |
| Houston John G | President and CEO | GRANT | N/A | 124K | — | Feb 27, 2024 |
| Cassidy Sean A | CFO | SELL | $50K–$100K | 2K | $47.05 | Feb 27, 2024 |
| Peck Ronald | Chief Medical Offi… | GRANT | N/A | 39K | — | Feb 27, 2024 |
| Peck Ronald | Chief Medical Offi… | SELL | $50K–$100K | 2K | $47.05 | Feb 27, 2024 |
| Taylor Ian | Chief Scientific O… | SELL | $50K–$100K | 2K | $47.05 | Feb 27, 2024 |
| Taylor Ian | Chief Scientific O… | GRANT | N/A | 39K | — | Feb 27, 2024 |
| Peck Ronald | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Aug 14, 2023 |
| Peck Ronald | Chief Medical Offi… | SELL | $15K–$50K | 1K | $24.39 | Aug 14, 2023 |
| Taylor Ian | Chief Scientific O… | SELL | $15K–$50K | 1K | $29.53 | Mar 4, 2023 |
| Taylor Ian | Chief Scientific O… | EXERCISE | N/A | 3K | — | Mar 4, 2023 |
| Houston John G | President and CEO | SELL | $100K–$500K | 6K | $29.53 | Mar 4, 2023 |
| Houston John G | President and CEO | EXERCISE | N/A | 18K | — | Mar 4, 2023 |
| Cassidy Sean A | CFO | EXERCISE | N/A | 5K | — | Mar 4, 2023 |
| Cassidy Sean A | CFO | SELL | $50K–$100K | 2K | $29.53 | Mar 4, 2023 |
| Peck Ronald | Chief Medical Offi… | SELL | $50K–$100K | 1K | $68.99 | Aug 16, 2022 |
| Peck Ronald | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Aug 16, 2022 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 16K | $16.00 | Apr 19, 2022 |
| Morrison Briggs | Director | SELL | $1M+ | 21K | $66.44 | Apr 19, 2022 |
| Cassidy Sean A | CFO | SELL | $1M+ | 15K | $70.00 | Mar 16, 2022 |
| Cassidy Sean A | CFO | EXERCISE | $100K–$500K | 15K | $16.00 | Mar 16, 2022 |
| Taylor Ian | Chief Scientific O… | EXERCISE | N/A | 3K | — | Mar 5, 2022 |
| Taylor Ian | Chief Scientific O… | SELL | $50K–$100K | 869 | $63.94 | Mar 5, 2022 |
| Cassidy Sean A | CFO | EXERCISE | N/A | 5K | — | Mar 5, 2022 |
| Cassidy Sean A | CFO | SELL | $100K–$500K | 2K | $63.94 | Mar 5, 2022 |
| Houston John G | President and CEO | EXERCISE | N/A | 18K | — | Mar 5, 2022 |
| Houston John G | President and CEO | SELL | $100K–$500K | 6K | $63.94 | Mar 5, 2022 |
| Taylor Ian | Chief Scientific O… | SELL | $1M+ | 20K | $73.02 | Feb 18, 2022 |
| Taylor Ian | Chief Scientific O… | EXERCISE | $100K–$500K | 20K | $19.36 | Feb 18, 2022 |
| Morrison Briggs | Director | SELL | $1M+ | 21K | $65.55 | Jan 20, 2022 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 16K | $16.00 | Jan 20, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 158 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PFIZER INC | 3.5M | $1M+ | SH |
| Point72 Asset Management, L.P. | 2.3M | $1M+ | SH |
| STATE STREET CORP | 1.8M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 1.2M | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 594K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 570K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 547K | $1M+ | SH |
| Nextech Invest, Ltd. | 539K | $1M+ | SH |
| CAXTON ASSOCIATES LLP | 455K | $1M+ | SH |
| Arbiter Partners Capital Management LLC | 453K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 443K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 425K | $1M+ | SH |
| Ikarian Capital, LLC | 358K | $1M+ | SH |
| BlackRock, Inc. | 311K | $1M+ | SH |
| AQR CAPITAL MANAGEMENT LLC | 306K | $1M+ | SH |
| Nantahala Capital Management, LLC | 300K | $1M+ | SH |
| WASATCH ADVISORS LP | 269K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 262K | $1M+ | SH |
| HRT FINANCIAL LP | 261K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 14, 2025
5.3%
3.4M shares
SC 13G/A · Nov 14, 2025
0.2%
143K shares
SC 13D/A · Oct 15, 2025
3.4%
2.5M shares
SC 13D/A · Aug 22, 2025
8.6%
6.3M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Aug 14, 2025
1.9%
1.3M shares
SC 13D · Jun 16, 2025
6.4%
4.8M shares
SC 13G/A · May 15, 2025
0.0%
0 shares
SC 13G/A · Apr 30, 2025
12.2%
8.4M shares
SC 13G/A · Apr 17, 2025
7.9%
5.4M shares
SC 13G/A · Feb 14, 2025
4.8%
3.3M shares
SC 13G · Jan 30, 2025
4.8%
3.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
5.6%
3.9M shares
SC 13G/A · Nov 14, 2024
4.1%
2.8M shares
SC 13G/A · Nov 12, 2024
9.5%
6.5M shares
SC 13G/A · Oct 22, 2024
9.5%
6.5M shares
The Vanguard Group - 23-1945930
SC 13G/A · Sep 10, 2024
10.3%
7.0M shares
SC 13G/A · Feb 14, 2024
10.0%
6.8M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2024
5.6%
3.8M shares
SC 13G · Feb 14, 2024
6.2%
4.2M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2024
4.4%
3.0M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2024
4.4%
3.0M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
7.1%
4.9M shares
SC 13G/A · Jan 26, 2024
7.9%
5.4M shares
SC 13G/A · Dec 11, 2023
4.0%
2.7M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2023
9.3%
5.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
4.4%
2.4M shares
SC 13G/A · Feb 13, 2023
5.9%
3.1M shares
Avidity Partners Management LP
SC 13G · Jun 16, 2022
6.1%
3.2M shares
SC 13G · May 16, 2022
5.9%
3.1M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2022
5.5%
2.9M shares
New Leaf Ventures III, L.P. (“NLV III”)
SC 13G/A · Feb 11, 2022
2.0%
1.1M shares
SC 13G/A · Jan 27, 2022
0.0%
0 shares